David Brocklebank
Director, Clinical Operations
David has over 35 years of experience in clinical development across the pharma, biotech and CRO industry in all phases of development, including senior roles in a wide variety of companies from start-up to large pharma. He has substantial experience managing early-stage clinical development, most recently Phase I first in human and patient studies whilst at Ono Pharma UK and prior to that at VC-backed biotech Outpost Medicine. Previously, at Mitsubishi Tanabe David led a global Phase III program recovery team in chronic kidney disease and was Managing Director at Kissei Pharma Europe leading Phase I-II clinical development programs. David holds a BPharm(Hons) in Pharmaceutical Chemistry from the University of Bradford and a post-graduate diploma in Clinical Science from the University of Wales, Cardiff.